HOME >> BIOLOGY >> NEWS
Univ. of Pittsburgh Medical Center leads group buying PPL'S cloning, stem cell business

th hyperacute rejection, thus removing a major immune barrier between pig and human and making transplants from animals to humans more feasible.

In January 2002, PPL announced the birth of pigs lacking one copy of this gene for the enzyme alpha1, 3 galactosyl transferase (alpha-gal), which adds a sugar to the surface of cells that the human immune system immediately recognizes as being foreign. Then in August of that year, PPL announced the birth of a litter of double-knockout pigs, each lacking both copies of the gene responsible for making the alpha-gal enzyme.

In recent studies performed by the PPL and Pittsburgh teams and reported in Science, cells taken from one of these double-knockout pigs did not elicit the usual hyperacute rejection response when transplanted into mice. These results and a description of the double-knockout pigs were published on the journal's Web site Dec. 19, 2002.

"It was fortuitous in many ways that we were able to establish a collaboration with PPL when we did. Indeed, the molecular biology work of Dr. Koike and others at the University of Pittsburgh provided PPL with an important piece to the puzzle that allowed their accomplishments with gene deletion to occur. In my opinion, it seems even more fortuitous that these teams can continue to work together, as their prior work will form the basis for moving forward into the future, and our team's recent discoveries related to the mechanisms of human engraftment and tolerance enhances an already impressive store of intellectual talent," noted John J. Fung, M.D., Ph.D., the Thomas E. Starzl Professor of Transplantation Surgery at the University of Pittsburgh School of Medicine and director of the Thomas E. Starzl Transplantation Institute.

According to Regenecor, there are currently five double-knockout pigs from two litters, three from a litter born in July 2002 and two that were born in September. Additionally, pregnancies from breeding of several singl
'"/>

Contact: Lisa Rossi
412-647-3555
University of Pittsburgh Medical Center
9-Apr-2003


Page: 1 2 3 4 5

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Univ. of Pittsburgh receives $6.3M NIH grant to study oral health disparities in Appalachia
3. Univ. of Fla. professor: Air cleaning system destroys Anthrax, other pathogens
4. University of Pittsburgh receives $10 million grant for head and neck cancer
5. University of Pittsburgh medical center among first to implant heart assist device
6. University of Pittsburgh receives NIH funding to develop heart assist device for infants
7. Pittsburgh NMR Center for Biomedical Research at Carnegie Mellon
8. University of Pittsburgh Medical Center acquires biotechnology firm Rheogene Inc.
9. Pittsburgh researchers engineer and successfully test SARS corona vaccine in animal model
10. Protein biomarkers accurately and quickly diagnose ALS, find Pittsburgh researchers
11. University of Pittsburgh scientist honored for major accomplishment in cancer research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... (PRWEB) , ... January 07, 2019 , ... ... and compliance solutions, is proud to welcome Thomas Kennedy as head of sales ... Miglicco, CEO for PureWay. , Mr. Kennedy has previously worked for Johnson & ...
(Date:1/7/2019)... ... January 07, 2019 , ... Franz Inc. , ... technology for Knowledge Graphs solutions, announced that it was recognized by Database ... DBTA’s data and information management recognition list includes newer approaches leveraging artificial intelligence, ...
(Date:1/4/2019)... (PRWEB) , ... January 03, 2019 , ... ... adopt 3D cell culture models into their drug discovery research workflows with biology ... improve the in vivo relevancy of in vitro studies, they create several challenges ...
Breaking Biology News(10 mins):
(Date:12/20/2018)... Colo. (PRWEB) , ... December 20, 2018 , ... New ... 2019, with major changes in regulations in the European Union (EU) on the horizon, ... companies to consider. , “The transition to the EU Medical Device Regulation (MDR), digital ...
(Date:12/19/2018)... ... December 19, 2018 , ... ... the validated release of Limfinity® version 7.1. The new release enhances the latest ... RURO as 2018 comes to an end. , Validation protocols, and their execution, ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM ... for the life sciences industry, unveiled a completely redesigned website at http://www.usdm.com ... user-friendly browsing experience for their valued clients and business partners. , The ...
(Date:12/14/2018)... ... December 14, 2018 , ... NOVA OCULUS PARTNERS, LLC, ... green light to immediately begin a clinical patient trial in Edmonton using their ... of Health Canada has granted what is called an Investigational Testing Authorization for ...
Breaking Biology Technology:
Cached News: